Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,122.23
(
-0.72%
)
US TECH 100
26,206.40
(
-1.37%
)
Dow Jones
49,182.59
(
-0.26%
)
Brent Oil
104.20
(
2.05%
)
Bitcoin
76,174.80
(
-1.55%
)
News Focus
News Focus
Post# of 257457
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 36
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: nuere post# 169536

Thursday, 11/07/2013 1:36:44 PM

Thursday, November 07, 2013 1:36:44 PM

Post# of 257457
Pipper Jaffray upgrades GERN



“The efficacy data appears compelling and is certainly sufficient for progression into a Geron-sponsored Phase 2 study,” Charles Duncan, an analyst with Piper Jaffray & Co., wrote today in a research note. He raised his price target for the shares to $10 from $6.


Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up